Skip to main content

Advertisement

SpringerLink
Log in

Age Disparities in Diagnosis of Prostate Cancer Between African Americans and Caucasians

  • Published:
Ageing International Aims and scope Submit manuscript

Abstract

Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer death in men. Age and ethnicity are two well-established risk factors for prostate cancer and have prominent influences on the onset, development, and outcomes of prostate cancer. This retrospective study reviewed more than 3,000 pathology reports on prostate surgical specimens and analyzed the associations of age and ethnicity with the onset, detection rate, and differentiation of prostate cancer. The results suggested that compared to Caucasian African American men had earlier onsets of PIN, ASAP, and prostate cancer by about one and a half years, and earlier onset of metastatic prostate cancer 9 years. Increased age is also associated with elevation of serum PSA in prostate cancer patients in both races. However, in this series neither age nor race was significantly associated with tumor grade (Gleason score).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Albain, K. S., Unger, J. M., Crowley, J. J., Coltman, C. A., Jr., & Hershman, D. L. (2009). Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. Journal of the National Cancer Institute, 101(14), 984–992. Epub 2009 Jul 7.

    Article  Google Scholar 

  • Alibhai, S. M., Krahn, M. D., Fleshner, N. E., Cohen, M. M., Tomlinson, G. A., & Naglie, G. (2004). The association between patient age and prostate cancer stage and grade at diagnosis. BJU International, 94(3), 303–306.

    Article  Google Scholar 

  • American Cancer Society. Cancer facts and figures. (2004). Available at http://www.cancer.org/docroot/STT/stt_0.asp. Accessed August 6.

  • American Cancer Society. Cancer Facts and Figures. (2009). Available at http://www.cancer.org/downloads/STT/500809web.pdf.

  • Babaian, R. J., Kojima, M., Ramirez, E. I., & Johnston, D. (1996). Comparative analysis of prostate specific antigen and its indexes in the detection of prostate cancer. Journal d’Urologie, 156(2 Pt 1), 432–437.

    Google Scholar 

  • Barroso, U., Jr., Oskanian, P., & Tefilli, M. (1999). Population-based study of pelvic lymph node positivity in clinically localized prostate cancer: a study comparing African Americans and whites. Urology, 53, 187–191.

    Article  Google Scholar 

  • Borek, D., Butcher, D., Hassanein, K., & Holmes, F. (1990). Relationship of age to histologic grade in prostate cancer. The Prostate, 16(4), 305–311.

    Article  Google Scholar 

  • Boyle, P. (2003). Screening for prostate cancer: have you had your cholesterol measured? BJU International, 92, 191–199.

    Article  Google Scholar 

  • Crawford, E. D. (2003). Epidemiology of prostate cancer. Urology, 62(6 Suppl 1), 3–12. Review.

    Article  Google Scholar 

  • Crawford, E. D., Hirano, D., Werahera, P. N., Lucia, M. S., DeAntoni, E. P., Daneshgari, F., et al. (1998). Computer modeling of prostate biopsy: tumor size and location–not clinical significance–determine cancer detection. Journal d'Urologie, 159(4), 1260–1264.

    Article  Google Scholar 

  • Cross, C. K., Shultz, D., Malkowicz, S. B., Huang, W. C., Whittington, R., Tomaszewski, J. E., et al. (2002). Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. Journal of Clinical Oncology, 20(12), 2863–2868.

    Article  Google Scholar 

  • Da Silva, F. C. (1997). Benign prostatic hyperplasia: natural evolution versus medical treatment. European Urology, 32(suppl 2), 34–37.

    Google Scholar 

  • DeAntoni, E. P., Crawford, E. D., Oesterling, J. E., Ross, C. A., Berger, E. R., McLeod, D. G., et al. (1996). Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology, 48(2), 234–239.

    Article  Google Scholar 

  • Draisma, G., Postma, R., Schröder, F. H., van der Kwast, T. H., & de Koning, H. J. (2006). Gleason score, age and screening: modeling dedifferentiation in prostate cancer. International Journal of Cancer, 119(10), 2366–2371.

    Article  Google Scholar 

  • Fowler, J. E., Jr., Bigler, S. A., Kilambi, N. K., & Land, S. A. (1999). Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies. Urology, 53(6), 1175–1178.

    Article  Google Scholar 

  • Grönberg, H. (2003). Prostate cancer epidemiology. Lancet, 361(9360), 859–864. Review.

    Article  Google Scholar 

  • Haas, G. P., & Sakr, W. A. (1997). Epidemiology of prostate cancer. CA: A Cancer Journal for Clinicians, 47(5), 273–287. Review.

    Article  Google Scholar 

  • Hodge, K. K., McNeal, J. E., Terris, M. K., & Stamey, T. A. (1989). Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. Journal d'Urologie, 142(1), 71–74. discussion 74–5.

    Google Scholar 

  • Hoffman, R. M., Gilliland, F. D., Eley, J. W., Harlan, L. C., Stephenson, R. A., Stanford, J. L., et al. (2001). Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute, 93, 388–395.

    Article  Google Scholar 

  • Johnson, D., Lanieri, J., & Ayala, A. (1972). Prostatic adenocarcinoma occurring in men under 50 years of age. Journal of Surgical Oncology, 4, 207.

    Article  Google Scholar 

  • Jones, B. A., Liu, W. L., Araujo, A. B., Kasl, S. V., Silvera, S. N., Soler-Vilá, H., et al. (2008). Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers & Prevention, 17(10), 2825–2834. Epub 2008 Sep 30.

    Article  Google Scholar 

  • Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A., et al. (1993). Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA, 270(7), 860–864.

    Article  Google Scholar 

  • Orozco, R., Kunnel, B., O’Dowd, G. J., & Stamey, T. A. (1998). Positive prostate biopsy rate consistently increases with age at the same prostate-specific antigen level in patients with normal digital rectal examination. Urology, 51(4), 531–533.

    Article  Google Scholar 

  • Platz, E. A., Smit, E., Curhan, G. C., Nyberg, L. M., & Giovannucci, E. (2002). Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in US men. Urology, 59, 877–883.

    Article  Google Scholar 

  • Polascik, T. J., Oesterling, J. E., & Partin, A. W. (1999). Prostate specific antigen: a decade of discovery – what we have learned and where we are going. Journal d’Urologie, 162, 293–303.

    Article  Google Scholar 

  • Powell, I. J., Banerjee, M., Sakr, W., Grignon, D., Wood, D. P., Jr., Novallo, M., et al. (1999). Should African-American men be tested for prostate carcinoma at an earlier age than white men? Cancer, 85, 472–477.

    Article  Google Scholar 

  • Robbins, A. S., Whittemore, A. S., & Thom, D. H. (2000). Differences in socioeconomic status and survival among white and black men with prostate cancer. American Journal of Epidemiology, 151, 409–416.

    Article  Google Scholar 

  • Sakr, W. A., Haas, G. P., Cassin, B. F., Pontes, J. E., & Crissman, J. D. (1993). The frequency of carcinoma and intraepithelial neoplasia of the prostate inyoung male patients. Journal d’Urologie, 150, 379–385.

    Google Scholar 

  • Sakr, W. A., Grignon, D. J., & Haas, G. P. (1998). Pathology of premalignant lesions and carcinoma of the prostate in African-American men. Seminars in Urologic Oncology, 16(4), 214–220.

    Google Scholar 

  • Sirovich, B. E., Schwartz, L. M., & Woloshin, S. (2003). Screening men for prostate and colorectalcancer in the United States: does practice reflect the evidence? JAMA, 289, 1414–1420.

    Article  Google Scholar 

  • Smedley, H. M., Sinnott, M., Freedman, L. S., Macaskill, P., Naylor, C. P., & Pillers, E. M. (1983). Age and survival in prostatic carcinoma. British Journal of Urology, 55(5), 529–533.

    Article  Google Scholar 

  • Smith, C. V., Bauer, J. J., Connelly, R. R., Seay, T., Kane, C., Foley, J., et al. (2000). Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. Journal d’Urologie, 164(6), 1964–1967.

    Article  Google Scholar 

  • Sölétormos, G., Semjonow, A., Sibley, P. E., Lamerz, R., Petersen, P. H., Albrecht, W., et al. (2005). Biological variation of total prostate specific antigen: a survey of published estimates and consequences for clinical practice. Clinical Chemistry, 51, 1342–1351.

    Article  Google Scholar 

  • Soos, G., Tsakiris, I., Szanto, J., Turzo, C., Haas, P. G., & Dezso, B. (2005). The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. European Urology, 48(5), 739–744. Epub 2005 Sep 15.

    Article  Google Scholar 

  • Stewart, C. S., Leibovich, B. C., Weaver, A. L., & Lieber, M. M. (2001). Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. Journal d’Urologie, 166(1), 86–91. discussion 91–2.

    Article  Google Scholar 

  • Tewari, A., Horninger, W., Badani, K. K., Hasan, M., Coon, S., Crawford, E. D., et al. (2005). Racial differences in serum prostate-specific antigen (PSA) double time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer. BJU International, 96(1), 29–33.

    Article  Google Scholar 

  • Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., et al. (2004). Prevalence of prostate cancer among men with a prostate-specific antigen level ≥4.0 ng per millilitre. The New England Journal of Medicine, 350, 2239–2246.

    Article  Google Scholar 

  • Tjaden, H., Culp, D., & Flocks, H. (1965). Clinical adenocarcinoma of the prostate in patients under 50 years of age. Journal d’Urologie, 93, 618.

    Google Scholar 

  • Yin, M., Bastacky, S., Chandran, U., Becich, M. J., & Dhir, R. (2008). Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. Urology, 179(3), 892–895. discussion 895. Epub 2008 Jan 22.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216, USA

    Xinchun Zhou & Steven A. Bigler

  2. Department of Surgery, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216, USA

    Charles R. Pound

Authors
  1. Xinchun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven A. Bigler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles R. Pound
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xinchun Zhou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, X., Bigler, S.A. & Pound, C.R. Age Disparities in Diagnosis of Prostate Cancer Between African Americans and Caucasians. Ageing Int 37, 186–194 (2012). https://doi.org/10.1007/s12126-010-9104-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12126-010-9104-x

Keywords

Search

Navigation